Top news of the week: 22.07.2021.
Career And Jobs
GSK's Planned UK Biotech and Life Sciences Hub to Create 5,000 Jobs
Master planning for the site is slated to begin in 2022 and will reportedly create one of the largest life sciences cluster in Europe.
Regeneron Plans to Create 1,000 New Jobs with $1.8 Billion Expansion in New York
Regeneron continues to expand its presence in New York. Over the next six years, the company will invest approximately $1.8 billion to expand its Tarrytown facilities. The investment will ...
Secrets and pies: the battle to get lab-grown meat on the menu
Sustainable alternatives to livestock farming are being held back by patents, a reluctance to share research and lack of government support
How Designer DNA Is Changing Medicine
A genomic revolution is poised to cure sickle cell and other genetic diseases
Vedanta raises $68M, reveals setback to Bristol Myers alliance
Vedanta Biosciences has raised $68 million to take a microbiome candidate into phase 3. The biotech also used the series D update to reveal the failure of its Bristol Myers Squibb ...
FDA’s domestic biopharma inspections return to normal as agency faces backlog of 8,000+
For the first time since March 2020, the FDA’s inspections of US-based biopharma sites have returned to normal, FDA acting commissioner Janet Woodcock said Monday at a small business ...
Q&A: Hitting 95% capacity in its new facility, MBI supports Worcester’s booming biotech sphere
MBI President and CEO Jon Weaver spoke with WBJ about the company’s history, its current growth, and new programming.
Ardelyx stock craters as FDA slaps biotech with dreaded ‘deficiencies’ tag on kidney drug
Shares in Ardelyx are in freefall after the FDA found a series of “deficiencies” with Ardelyx’s application for the kidney disease hopeful tenapanor. In what CEO Mike Raab said was an ...